On September 26, the 2025 Private Economy Innovation and Development Conference & Conference on Renowned Private Enterprises Boosting High-quality Development of Shaanxi was jointly held in Xi’an by the All-China Federation of Industry and Commerce and the People’s Government of Shaanxi Province. Gao Yunlong, Vice Chairman of the National Committee of the Chinese People’s Political Consultative Conference and Chairman of the All-China Federation of Industry and Commerce, attended the event and delivered a speech. The 2025 Top 500 Private Enterprises by Invention Patents List was released at the conference. Drawing on abundant patent reserves and outstanding innovation capabilities, Good Doctor Group stood out from numerous outstanding enterprises and successfully made it onto this prestigious list.

Private enterprises have become a vital force for implementing the innovation-driven development strategy and advancing high-quality economic growth. Data from the list shows that the threshold for inclusion in the 2025 Top 500 Private Enterprises by Invention Patents has risen to 187 patents. Collectively, listed enterprises hold as many as 598,100 valid domestic invention patents, averaging 1,196 patents per enterprise, fully demonstrating the robust innovation vitality of the private economy. Notably, only 29 enterprises nationwide were selected within the fiercely competitive pharmaceutical manufacturing sector featuring high technical barriers. Good Doctor Group’s inclusion serves as authoritative recognition of its long-term commitment to scientific and technological innovation and achievements in building a robust intellectual property system.

This honor did not come by chance. It represents the highest recognition of Good Doctor Group’s persistent investment in technological innovation and its establishment of a full-life-cycle intellectual property system covering discovery, layout and management. This systematic methodology acts as the core engine driving innovation, protecting intellectual achievements and securing competitive advantages in the marketplace. In recent years, the Group has been awarded the title of National Intellectual Property Demonstration Enterprise. It has filed more than 1,000 patent applications and owns over 2,000 registered trademarks. One of its patented technologies won the Excellent Award of the China Patent Award, while two obtained the Second Prize of the Sichuan Provincial Patent Award.

Intellectual property management rests on solid organizational foundations. Under the leadership of Chairman Geng Funeng, the enterprise has placed technological innovation at the heart of its overall development since its founding and elevated intellectual property to a core corporate strategy. Supported by the National Enterprise Technology Center, National Postdoctoral Research Station, Provincial Academician (Expert) Workstation, Provincial Key Laboratory, Provincial Engineering Technology Center and Industry-University-Research Joint Laboratory, the Group has undertaken national, provincial and ministerial major scientific research projects. An intellectual property department has been established to bring together interdisciplinary professional talents and experts. The Group was among the first in the industry to obtain certification for the intellectual property management system, fully aligning with national high standards. All work from strategic planning to process implementation meets high standards of standardization, normalization and systematization, laying a solid institutional foundation for sustained innovation.

For the discovery of invention patents covering core technologies, the Group has formed a unique mechanism of early intervention and full-process empowerment through guided project initiation, periodic screening and value assessment. For core technologies identified through precise exploration, the Group adopts the strategic mindset of patent deployment prior to product launch and the international vision of building an “intellectual property shield”. It has established a full-life-cycle patent management system featuring standardized workflows, regular risk control and diversified operations, effectively transforming intellectual property into core corporate assets and competitiveness. Furthermore, the Group has built a comprehensive institutional framework including Confidentiality Regulations, Patent Management Regulations, Trademark Management Regulations and Copyright Management Regulations, delivering all-round institutional safeguards for the entire innovation ecosystem.

Being listed on the 2025 Top 500 Private Enterprises by Invention Patents fully acknowledges Good Doctor Group’s long-term dedication and accumulated achievements in intellectual property, and also serves as a strong incentive for continuous innovation and leading development in the future. Moving forward, Good Doctor Group will further refine its systematic intellectual property strategy. Through more targeted innovation discovery, forward-looking global layout and efficient asset management, the Group will promote the generation and application of more high-value patents. It will embed intellectual property — the “golden key” to high-quality development — deep into the development of core competitiveness, and contribute greater strength to the innovative upgrading of China’s pharmaceutical industry and its march toward the high end of the global value chain.